drugset / Trial / NCT03648229
African Glaucoma Laser Trial
Phase 4
Withdrawn
West Virginia University
University of Michigan · collabUniversity of Pittsburgh · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
The AGLT is a prospective, multicenter, randomized study in which adult black Africans with treatment-naive open-angle glaucoma are assigned to therapy with selective laser trabeculoplasty (SLT), medications provided at no cost (MED), or medications provided by prescription for subjects to obtain at their own expense as per usual care (RX). The overall goal of the AGLT is to determine the best treatment strategy for newly-diagnosed open-angle glaucoma in Africa.
Timeline
- Start
- 2019-09-01
- Primary completion
- 2022-06-30
- Completion
- 2024-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Latanoprost | Small molecule | 0.005 % | Topical |
| Comparator | Timolol | Other / unclassified | 0.5 % | — |